Supermind

supermind is building trusted access points to psychedelic medicine, starting with psychedelics.com (launching mid-2022), to massively scale consumer education and patient enrollment in psychedelic-assisted therapy. we support consumers through a lifetime of wellness while enabling professionals to attract an abundance of patients. we can deliver compliant patient enrollment at scale through comprehensive digital properties, trusted treatment marketplaces, and extensive data and audience tools. our leadership and advisors bring over a decade of experience producing value within the addiction treatment, mental health, and behavioral health industries. what we’ve done in the past: * serving more than 200m visitors with credible, medically-reviewed health content and treatment resources at critical points in their lives * $100m+ revenue generated for behavioral health facilities * $220m m&a as founders and c-suite executives * $100m+ annual organic traffic value (seo/earned media)